PRTA Q4 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+571.8% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$65M-3056.9% margin

Net Income

-$58M-2729.9% margin

EPS (Diluted)

$-1.08

QoQ Revenue Growth

+118.9%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$547M

Total Liabilities

$60M

Stockholders' Equity

$487M

Cash & Equivalents

$471M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$316,000	+571.8%
Gross Profit	$2M	-$62M	+103.4%
Operating Income	-$65M	-$79M	+17.3%
Net Income	-$58M	-$67M	+14.1%

Revenue Segments

Collaboration

$134M100%